-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Plus Therapeutics, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2023.
- Plus Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $34K, a 24.4% decline year-over-year.
- Plus Therapeutics, Inc. Operating Lease, Payments for the twelve months ending March 31, 2023 was $148K, a 26.7% decline year-over-year.
- Plus Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $141K, a 11.3% decline from 2022.
- Plus Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $159K, a 22.8% decline from 2021.
- Plus Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $206K, a 0.98% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)